{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:08:52Z","timestamp":1760548132521,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.tox.2005.06.018","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T16:49:16Z","timestamp":1123087756000},"page":"256-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acute inhalative exposure assessment: Derivation of guideline levels with special regard to sensitive subpopulations and time scaling"],"prefix":"10.1016","volume":"214","author":[{"given":"Hans","family":"Mielke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gundert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Gundert-Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2005.06.018_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00204-004-0599-3","article-title":"Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration","volume":"79","author":"Abraham","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2005.06.018_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1742-7843.2005.pto960315.x","article-title":"Internal exposure of children by acute inhalation of volatile organic compounds: the influence of chemical properties on the child\/adult concentration ratio","volume":"96","author":"Abraham","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"year":"2003","series-title":"Acute Exposure Guideline Levels for Selected Airborne Chemicals","author":"AEGL-Committee","key":"10.1016\/j.tox.2005.06.018_bib3"},{"key":"10.1016\/j.tox.2005.06.018_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1006\/faat.1994.1133","article-title":"Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels","volume":"23","author":"Allen","year":"1994","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2005.06.018_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","article-title":"Physiologically based pharmacokinetics and the risk assessment process for methylene chloride","volume":"87","author":"Andersen","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib6","series-title":"Modeling of Inhalation Exposure to Vapor: Uptake, Distribution, and Elimination","first-page":"107","article-title":"Effect of physical exercise on uptake, distribution and elimination of vapors in man","author":"Astrand","year":"1983"},{"key":"10.1016\/j.tox.2005.06.018_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/rtph.1995.1043","article-title":"Benchmark dose workshop: Criteria for use of a benchmark dose to estimate a reference dose","volume":"21","author":"Barnes","year":"1995","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/rtph.1996.0115","article-title":"Uncertainty factors in noncancer risk assessment","volume":"24","author":"Dourson","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib9","unstructured":"EC, 1996. Council Directive 96\/82\/EC of 9 December 1996 on the control of major-accident hazards involving dangerous substances (Official Journal L 010 of 14 January 1997 pp. 0013\u20130033)."},{"key":"10.1016\/j.tox.2005.06.018_bib10","unstructured":"EPA, 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA\/600\/8-90\/066F, Environmental Criteria and Assessment Office, Office of Research and Development, Research Triangle Park, NC."},{"key":"10.1016\/j.tox.2005.06.018_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/rtph.1999.1295","article-title":"The use of benchmark dose methodology with acute inhalation lethality data","volume":"29","author":"Fowles","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-008X(86)90196-1","article-title":"Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways","volume":"82","author":"Gargas","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/rtph.1996.0137","article-title":"Quantalization of continuous data for benchmark dose estimation","volume":"24","author":"Gaylor","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/rtph.1998.1279","article-title":"A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty\/safety factors","volume":"29","author":"Gaylor","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/rtph.1998.1247","article-title":"Procedures for calculating benchmark doses for health risk assessment","volume":"28","author":"Gaylor","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0048-9697(01)01108-1","article-title":"The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective","volume":"288","author":"Gundert-Remy","year":"2002","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.tox.2005.06.018_bib17","series-title":"F\u00fcnf Vortr\u00e4ge aus den Jahren 1920\u20131923","first-page":"76","article-title":"Zur Geschichte des Gaskrieges","author":"Haber","year":"1924"},{"key":"10.1016\/j.tox.2005.06.018_bib18","first-page":"273","article-title":"Pharmacokinetic and pharmacodynamic modeling in vivo","volume":"5","author":"Holford","year":"1981","journal-title":"CRC Crit. Rev. Bioeng."},{"key":"10.1016\/j.tox.2005.06.018_bib19","first-page":"323","article-title":"Modeling of respiratory exchange of polar-solvents","volume":"35","author":"Johanson","year":"1991","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.tox.2005.06.018_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/clpt.1994.155","article-title":"Physiologic indirect effect models characterize diverse types of pharmacodynamic effect","volume":"56","author":"Jusko","year":"1995","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.tox.2005.06.018_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0273-2300(92)90047-D","article-title":"Statistical properties of the NOAEL","volume":"15","author":"Leisenring","year":"1992","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2005.06.018_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10590509409373434","article-title":"Approach to assessment of risk to human health for priority substances under the Canadian Environmental Protection","volume":"12","author":"Meek","year":"1994","journal-title":"Act. Environ. Carcinogen. Ecotoxicol. Rev."},{"year":"2001","series-title":"Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals","author":"NRC","key":"10.1016\/j.tox.2005.06.018_bib23"},{"year":"1993","series-title":"Guidelines for Developing Community Emergency Exposure Levels for Hazardous Substances.","author":"NRC","key":"10.1016\/j.tox.2005.06.018_bib24"},{"year":"1997","series-title":"Addressing Priority Data Needs for Methylene Chloride with Physiologically Based Pharmacokinetic Modeling","author":"Reitz","key":"10.1016\/j.tox.2005.06.018_bib25"},{"key":"10.1016\/j.tox.2005.06.018_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02652039309374152","article-title":"Data-derived safety factors for the evaluation of food additives and environmental contaminants","volume":"10","author":"Renwick","year":"1993","journal-title":"Food Addit. Contam."},{"key":"10.1016\/j.tox.2005.06.018_bib27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00028896409342641","article-title":"Concentration-time product (CT) as an expression of dose in sublethal exposures of phosgene","volume":"25","author":"Rinehart","year":"1964","journal-title":"Am. Ind. Hyg. Assoc. J."},{"key":"10.1016\/j.tox.2005.06.018_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0304-3894(86)85003-8","article-title":"Concentration-time mortality response relationship of irritant and systemically acting vapors and gases","volume":"13","author":"ten Berge","year":"1986","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.tox.2005.06.018_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1432-1033.1996.0476z.x","article-title":"Developmental expression of CYP2E1 in the human liver \u2013 hypermethylation control of gene expression during the neonatal period","volume":"238","author":"Vieira","year":"1996","journal-title":"Eur. J. Biochem."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X05002908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X05002908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:52:35Z","timestamp":1759531955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X05002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0300483X05002908"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2005.06.018","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute inhalative exposure assessment: Derivation of guideline levels with special regard to sensitive subpopulations and time scaling","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2005.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}